Research on typhoid vaccine effectiveness begins

icddr,b in collaboration with Dhaka North City Corporation and Expanded Programme on Immunization of Bangladesh have commenced a typhoid conjugate vaccine  effectiveness study among 43,350 children between 9 months and under 16 years of age, living in Mirpur in the capital yesterday, says a press release.

The study is a part of the Typhoid Vaccine Acceleration Consortium (TyVAC) project, in which researchers are conducting studies to evaluate just how much typhoid can be prevented by the typhoid conjugate vaccine in Bangladesh. Studies are also ongoing in Malawi and Nepal.  

Globally, about one hundred and fifty thousand patients die due to typhoid every year but it causes severe illness in others.

Research on typhoid vaccine effectiveness begins

icddr,b in collaboration with Dhaka North City Corporation and Expanded Programme on Immunization of Bangladesh have commenced a typhoid conjugate vaccine effectiveness study among 43,350 children between 9 months and under 16 years of age, living in Mirpur in the capital yesterday, says a press release. The study is a part of the Typhoid Vaccine Acceleration Consortium (TyVAC) project, in which researchers are conducting studies to evaluate just how much typhoid can be prevented by the typhoid conjugate vaccine in Bangladesh. Studies are also ongoing in Malawi and Nepal. Globally, about one hundred and fifty thousand patients die due to typhoid every year but it causes severe illness in others.